Extract and peptides derived from Oryza sativa Japonica Group and uses thereof
US8765679B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jun 29, 2010 |
| Grant date | Jul 1, 2014 |
| Priority date | — |
| Expiry date | Jun 29, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/285
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to isolated peptides derived from Oryza sativa Japonica Group, pharmaceutical compositions comprising same, and uses thereof for treating, preventing, ameliorating, and/or delaying the onset of inflammatory and/or neuroinflammatory and/or autoimmune diseases or conditions and in particular multiple sclerosis. The invention further relates to extracts from Oryza sativa Japonica Group and use thereof as a dietary supplement or in a pharmaceutical composition for treating, preventing, ameliorating, and/or delaying the onset of inflammatory, and/or inflammatory, neuroinflammatory and/or autoimmune diseases or conditions. The peptides and the extract of the invention may be used for treating, ameliorating, and/or delaying the onset or preventing multiple sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.